{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:07:37Z","timestamp":1766167657991,"version":"3.48.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03550-1","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T11:17:35Z","timestamp":1746271055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of topographic, aberrometric, and endothelial cell features of the cornea in Fabry disease"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7109-4778","authenticated-orcid":false,"given":"K\u00fcbra","family":"Kahraman Ko\u00e7","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7795-5188","authenticated-orcid":false,"given":"Nesrin","family":"B\u00fcy\u00fcktortop G\u00f6k\u00e7inar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6457-149X","authenticated-orcid":false,"given":"Selda Fatma","family":"B\u00fclb\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"3550_CR1","volume-title":"Fabry disease","author":"SRA Bokhari","year":"2023","unstructured":"Bokhari SRA, Zulfiqar H, Hariz A (2023) Fabry disease. StatPearls Publishing, Treasure Island (FL)"},{"key":"3550_CR2","doi-asserted-by":"crossref","first-page":"4696429","DOI":"10.1155\/2019\/4696429","volume":"2019","author":"A Sodi","year":"2019","unstructured":"Sodi A, Lenzetti C, Bacherini D et al (2019) Quantitative analysis of conjunctival and retinal vessels in Fabry disease. J Ophthalmol 2019:4696429","journal-title":"J Ophthalmol"},{"key":"3550_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00003226-200103000-00028","volume":"20","author":"K Hirano","year":"2001","unstructured":"Hirano K, Murata K, Miyagawa A et al (2001) Histopathologic findings of cornea verticillata in a woman heterozygous for Fabry\u2019s disease. Cornea 20:233\u2013236","journal-title":"Cornea"},{"key":"3550_CR4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/jcm10051093","volume":"10","author":"MRJ Wiest","year":"2021","unstructured":"Wiest MRJ, Toro MD, Nowak A et al (2021) Globotrioasylsphingosine levels and optical coherence tomography angiography in Fabry disease patients. J Clin Med 10:1093","journal-title":"J Clin Med"},{"key":"3550_CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s13023-022-02441-3","volume":"17","author":"M Marenco","year":"2022","unstructured":"Marenco M, Segatto M, Sacchetti M et al (2022) Autophagy-lysosome pathway alteration in ocular surface manifestations in Fabry disease patients. Orphanet J Rare Dis 17:291","journal-title":"Orphanet J Rare Dis"},{"key":"3550_CR6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/jpm13060904","volume":"13","author":"G Gambini","year":"2023","unstructured":"Gambini G, Scartozzi L, Giannuzzi F et al (2023) Ophthalmic manifestations in Fabry disease: updated review. J Pers Med 13:904","journal-title":"J Pers Med"},{"key":"3550_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13023-022-02215-x","volume":"17","author":"F Ezgu","year":"2022","unstructured":"Ezgu F, Alpsoy E, Bicik Bahcebasi Z et al (2022) Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective. Orphanet J Rare Dis 17:90","journal-title":"Orphanet J Rare Dis"},{"key":"3550_CR8","unstructured":"Sodi A, Ioannidis A, Pitz S (2006) Chapter 26. Ophthalmological manifestations of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, eds. Fabry disease: perspectives from 5 years of FOS. Oxford PharmaGenesis, Oxford"},{"key":"3550_CR9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00417-019-04593-8","volume":"258","author":"V Cankurtaran","year":"2020","unstructured":"Cankurtaran V, Tekin K, Cakmak AI et al (2020) Assessment of corneal topographic, tomographic, densitometric, and biomechanical properties of Fabry patients with ocular manifestations. Graefes Arch Clin Exp Ophthalmol 258:1057\u20131064","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3550_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13023-019-1267-2","volume":"14","author":"Y Atiskova","year":"2019","unstructured":"Atiskova Y, Rassuli R, Koehn AF et al (2019) Retinal hyperreflective foci in Fabry disease. Orphanet J Rare Dis 14:296","journal-title":"Orphanet J Rare Dis"},{"key":"3550_CR11","doi-asserted-by":"crossref","first-page":"2226909","DOI":"10.1080\/07853890.2023.2226909","volume":"55","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhang W, Yao X et al (2023) Investigation of ocular involvement in patients with Fabry disease. Ann Med 55:2226909","journal-title":"Ann Med"},{"key":"3550_CR12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13023-023-02932-x","volume":"18","author":"M Lindziute","year":"2023","unstructured":"Lindziute M, Kaufeld J, Hufendiek K et al (2023) Correlation of retinal vascular characteristics with laboratory and ocular findings in Fabry disease: exploring ocular diagnostic biomarkers. Orphanet J Rare Dis 18:314","journal-title":"Orphanet J Rare Dis"},{"key":"3550_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2017.09.017","volume":"184","author":"E Shimizu","year":"2017","unstructured":"Shimizu E, Yamaguchi T, Tomida D et al (2017) Corneal higher-order aberrations and visual improvement following corneal transplantation in treating herpes simplex keratitis. Am J Ophthalmol 184:1\u201310","journal-title":"Am J Ophthalmol"},{"key":"3550_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2016.12.014","volume":"175","author":"E Shimizu","year":"2017","unstructured":"Shimizu E, Yamaguchi T, Yagi-Yaguchi Y et al (2017) Corneal higher-order aberrations in infectious keratitis. Am J Ophthalmol 175:148\u2013158","journal-title":"Am J Ophthalmol"},{"issue":"suppl 1","key":"3550_CR15","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/ICO.0000000000001388","volume":"36","author":"T Yamaguchi","year":"2017","unstructured":"Yamaguchi T, Shimizu E, Yagi-Yaguchi Y et al (2017) A novel entity of corneal diseases with irregular posterior corneal surfaces: concept and clinical relevance. Cornea 36(suppl 1):S53\u2013S59","journal-title":"Cornea"},{"key":"3550_CR16","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1097\/ICL.0000000000000394","volume":"44","author":"H Yazu","year":"2018","unstructured":"Yazu H, Yamaguchi T, Dogru M et al (2018) Decreased visual acuity by an irregular corneal posterior surface after repeat descemet stripping automated endothelial keratoplasty. Eye Contact Lens 44:S249\u2013S254","journal-title":"Eye Contact Lens"},{"key":"3550_CR17","doi-asserted-by":"crossref","first-page":"e0218108","DOI":"10.1371\/journal.pone.0218108","volume":"14","author":"J Wasielica-Poslednik","year":"2019","unstructured":"Wasielica-Poslednik J, Schuster AK, Politino G et al (2019) Corneal topometric, aberrometric and biomechanical parameters in mucopolysaccharidosis patients. PLoS ONE 14:e0218108","journal-title":"PLoS ONE"},{"key":"3550_CR18","doi-asserted-by":"crossref","first-page":"12244","DOI":"10.1038\/s41598-018-30688-z","volume":"8","author":"G Bitirgen","year":"2018","unstructured":"Bitirgen G, Turkmen K, Malik RA et al (2018) Corneal confocal microscopy detects corneal nerve damage and increased dendritic cells in Fabry disease. Sci Rep 8:12244","journal-title":"Sci Rep"},{"key":"3550_CR19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/biom11020271","volume":"11","author":"K Kok","year":"2021","unstructured":"Kok K, Zwiers KC, Boot RG et al (2021) Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions. Biomolecules 11:271","journal-title":"Biomolecules"},{"key":"3550_CR20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013346","journal-title":"Ann Intern Med"},{"key":"3550_CR21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/13816810.2022.2132515","volume":"43","author":"M Nilsson","year":"2022","unstructured":"Nilsson M, Kolagari HT, Epstein D et al (2022) Visual outcome, ocular findings, and visual quality of life in patients with Fabry disease. Ophthalmic Genet 43:841\u2013849","journal-title":"Ophthalmic Genet"},{"key":"3550_CR22","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s10792-022-02626-6","volume":"43","author":"A Mete","year":"2023","unstructured":"Mete A, Dogan L, Ozcakmakci GB et al (2023) Ocular findings and their correlation with disease severity in Fabry disease in South-East Anatolia. Int Ophthalmol 43:2301\u20132306","journal-title":"Int Ophthalmol"},{"key":"3550_CR23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30","journal-title":"Orphanet J Rare Dis"},{"key":"3550_CR24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0004-27492011000600014","volume":"74","author":"FY Yonamine","year":"2011","unstructured":"Yonamine FY, Arantes TE, Muccioli C (2011) Fabry disease - importance of screening in cornea verticillata: case report. Arq Bras Oftalmol 74:447\u2013448","journal-title":"Arq Bras Oftalmol"},{"key":"3550_CR25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.amjms.2020.07.011","volume":"360","author":"M Michaud","year":"2020","unstructured":"Michaud M, Mauhin W, Belmatoug N et al (2020) When and how to diagnose Fabry disease in clinical pratice. Am J Med Sci 360:641\u2013649","journal-title":"Am J Med Sci"},{"key":"3550_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.sjopt.2016.12.005","volume":"31","author":"C Degirmenci","year":"2017","unstructured":"Degirmenci C, Yilmaz SG, Onay H et al (2017) A novel mutation and in vivo confocal microscopic findings in Fabry disease. Saudi J Ophthalmol 31:45\u201347","journal-title":"Saudi J Ophthalmol"},{"key":"3550_CR27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7705\/biomedica.3841","volume":"39","author":"K Rothstein","year":"2019","unstructured":"Rothstein K, G\u00e1lvez JM, Guti\u00e9rrez \u00c1M et al (2019) Ocular findings in Fabry disease in Colombian patients. Biomedica 39:434\u2013439","journal-title":"Biomedica"},{"key":"3550_CR28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.survophthal.2008.04.005","volume":"53","author":"N Samiy","year":"2008","unstructured":"Samiy N (2008) Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder. Surv Ophthalmol 53:416\u2013423","journal-title":"Surv Ophthalmol"},{"key":"3550_CR29","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/OPX.0b013e31827ec7eb","volume":"90","author":"MD Sivley","year":"2013","unstructured":"Sivley MD (2013) Fabry disease: a review of ophthalmic and systemic manifestations. Optom Vis Sci 90:e63\u2013e78","journal-title":"Optom Vis Sci"},{"key":"3550_CR30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5935\/0004-2749.20220061","volume":"85","author":"C Arici","year":"2022","unstructured":"Arici C, Sultan P, Mergen B (2022) Evaluation of the impact of subepithelial corneal infiltrates on corneal biomechanics after epidemic keratoconjunctivitis. Arq Bras Oftalmol 85:478\u2013484","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"3550_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ICO.0b013e3181b55cc1","volume":"29","author":"U Kottler","year":"2010","unstructured":"Kottler U, Demir D, Schmidtmann I et al (2010) Central corneal thickness in mucopolysaccharidosis II and VI. Cornea 29(3):260\u2013262","journal-title":"Cornea"},{"issue":"1","key":"3550_CR32","doi-asserted-by":"crossref","first-page":"e0168698","DOI":"10.1371\/journal.pone.0168698","volume":"12","author":"J Wasielica-Poslednik","year":"2017","unstructured":"Wasielica-Poslednik J, Politino G, Schmidtmann I et al (2017) Influence of corneal opacity on intraocular pressure assessment in patients with lysosomal storage diseases. PLoS ONE 12(1):e0168698","journal-title":"PLoS ONE"},{"issue":"11","key":"3550_CR33","doi-asserted-by":"crossref","first-page":"e0239124","DOI":"10.1371\/journal.pone.0239124","volume":"15","author":"J Buffault","year":"2020","unstructured":"Buffault J, Z\u00e9boulon P, Liang H, Chiche A, Luzu J, Robin M, Rabut G, Labetoulle M, Labb\u00e9 A, Baudouin C (2020) Assessment of corneal epithelial thickness mapping in epithelial basement membrane dystrophy. PLoS ONE 15(11):e0239124","journal-title":"PLoS ONE"},{"key":"3550_CR34","doi-asserted-by":"crossref","first-page":"e0213329","DOI":"10.1371\/journal.pone.0213329","volume":"14","author":"L Michaud","year":"2019","unstructured":"Michaud L (2019) Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease. PLoS ONE 14:e0213329","journal-title":"PLoS ONE"},{"key":"3550_CR35","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2147\/OPTH.S255086","volume":"14","author":"Z Alzaben","year":"2020","unstructured":"Alzaben Z, Gammoh Y, Freixas M et al (2020) Inter-ocular asymmetry in anterior corneal aberrations using Placido disk-based topography. Clin Ophthalmol 14:1451\u20131457","journal-title":"Clin Ophthalmol"},{"key":"3550_CR36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cxo.12828","volume":"102","author":"K Tekin","year":"2019","unstructured":"Tekin K, Kiziltoprak H, Koc M et al (2019) The effect of corneal infiltrates on densitometry and higher-order aberrations. Clin Exp Optom 102:140\u2013146","journal-title":"Clin Exp Optom"},{"key":"3550_CR37","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/ICO.0000000000000910","volume":"35","author":"E Kashizuka","year":"2016","unstructured":"Kashizuka E, Yamaguchi T, Yaguchi Y et al (2016) Corneal higher-order aberrations in herpes simplex keratitis. Cornea 35:1562\u20131568","journal-title":"Cornea"},{"key":"3550_CR38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/ICL.0000000000000530","volume":"45","author":"E Shimizu","year":"2019","unstructured":"Shimizu E, Yamaguchi T, Tsubota K et al (2019) Corneal higher-order aberrations in eyes with corneal scar after traumatic perforation. Eye Contact Lens 45:124\u2013131","journal-title":"Eye Contact Lens"},{"key":"3550_CR39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/OPX.0000000000001134","volume":"94","author":"K Kamiya","year":"2017","unstructured":"Kamiya K, Kobashi H, Takahashi M et al (2017) Effect of scattering and aberrations on visual acuity for band keratopathy. Optom Vis Sci 94:1009\u20131014","journal-title":"Optom Vis Sci"},{"key":"3550_CR40","first-page":"e1098","volume":"97","author":"S Koh","year":"2019","unstructured":"Koh S, Haruna M, Asonuma S et al (2019) Quantitative evaluation of visual function in patients with cornea verticillata associated with Fabry disease. Acta Ophthalmol 97:e1098\u2013e1104","journal-title":"Acta Ophthalmol"},{"key":"3550_CR41","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2147\/OPTH.S66748","volume":"8","author":"PG Davey","year":"2014","unstructured":"Davey PG (2014) Fabry disease: a survey of visual and ocular symptoms. Clin Ophthalmol 8:1555\u20131560","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3550_CR42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40123-022-00503-0","volume":"11","author":"M Moshirfar","year":"2022","unstructured":"Moshirfar M, Bundogji N, Tukan AN et al (2022) Implications of corneal refractive surgery in patients with Fabry disease. Ophthalmol Ther 11(3):925\u2013929","journal-title":"Ophthalmol Ther"},{"key":"3550_CR43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/ATVBAHA.113.302744","volume":"34","author":"K Satoh","year":"2014","unstructured":"Satoh K (2014) Globotriaosylceramide induces endothelial dysfunction in Fabry disease. Arterioscler Thromb Vasc Biol 34:2\u20134","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03550-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03550-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03550-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:02:45Z","timestamp":1766167365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03550-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3550"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03550-1","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"169"}}